Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.
about
External validation of a PCA-3-based nomogram for predicting prostate cancer and high-grade cancer on initial prostate biopsy.The role of prostate cancer biomarkers in undiagnosed men.Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry.
P2860
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Optimizing the clinical utilit ...... er in initial prostate biopsy.
@ast
Optimizing the clinical utilit ...... er in initial prostate biopsy.
@en
type
label
Optimizing the clinical utilit ...... er in initial prostate biopsy.
@ast
Optimizing the clinical utilit ...... er in initial prostate biopsy.
@en
prefLabel
Optimizing the clinical utilit ...... er in initial prostate biopsy.
@ast
Optimizing the clinical utilit ...... er in initial prostate biopsy.
@en
P2093
P2860
P50
P1433
P1476
Optimizing the clinical utilit ...... cer in initial prostate biopsy
@en
P2093
Alvaro Gómez-Ferrer
Ana Calatrava
Angel Borque
Antonio Fernandez-Serra
Argimiro Collado
Francisco Martínez
Inmaculada Iborra
Jose A Lopez-Guerrero
Jose Domínguez-Escrig
Jose Rubio-Briones
P2860
P2888
P356
10.1186/S12885-015-1623-0
P407
P577
2015-09-11T00:00:00Z
P5875
P6179
1013352194